UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study

Annals of oncology, 2012-06, Vol.23 (6), p.1422-1427

2012

Volltextzugriff (PDF)

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer

Breast cancer research and treatment, 2011-07, Vol.128 (2), p.447-456

2011

Volltextzugriff (PDF)

The pharmacological treatment of aggressive fibromatosis: a systematic review

Annals of oncology, 2003-02, Vol.14 (2), p.181-190

2003

Volltextzugriff (PDF)

Cutaneous toxicities of antineoplastic agents: data from a large cohort of Greek patients

Supportive care in cancer, 2019-12, Vol.27 (12), p.4535-4542

2019

Volltextzugriff (PDF)

Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)

Annals of oncology, 2013-04, Vol.24 (4), p.1011-1017

2013

Volltextzugriff (PDF)

A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer

British journal of cancer, 2006-09, Vol.95 (5), p.587-592

2006

Volltextzugriff (PDF)

Association between genetic polymorphisms in long non-coding RNAs and pancreatic cancer risk

Cancer biomarkers : section A of Disease markers, 2019-01, Vol.24 (1), p.117-123

2019

Volltextzugriff (PDF)

Recurrence rate in colorectal adenocarcinoma patients receiving adjuvant capecitabine monotherapy: do the number of chemotherapy cycles and relative dose intensity of the drug play a role?

Annals of oncology, 2019-07, Vol.30, p.iv59-iv59

2019

Volltextzugriff (PDF)

ABREAST: a prospective, real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and quality of life of patients with metastatic breast cancer

Breast cancer research and treatment, 2020-07, Vol.182 (1), p.85-96

2020

Volltextzugriff (PDF)

Afatinib in combination with cisplatin and 5-fluorouracil (5-FU) as first line treatment in inoperable gastric and gastro-esophageal junction (GEJ) cancer: A phase II study by the Hellenic Cooperative Oncology Group

Annals of oncology, 2018-10, Vol.29, p.viii227-viii228

2018

Volltextzugriff (PDF)

Primary fallopian tube carcinoma: Results of a retrospective analysis of 64 patients

Gynecologic oncology, 2009-10, Vol.115 (1), p.97-101

2009

Volltextzugriff (PDF)

Cyclin D1 differential activation and its prognostic impact among advanced breast cancer patients treated with trastuzumab

Annals of oncology, 2018-10, Vol.29, p.viii45-viii46

2018

Volltextzugriff (PDF)

Docetaxel and Cisplatin With Granulocyte Colony-Stimulating Factor (G-CSF) Versus MVAC With G-CSF in Advanced Urothelial Carcinoma: A Multicenter, Randomized, Phase III Study From the Hellenic Cooperative Oncology Group

Journal of clinical oncology, 2004-01, Vol.22 (2), p.220-228

2004

Volltextzugriff (PDF)

Prevention and prophylaxis of thrombosis in cancer patients

Annals of oncology, 2018-10, Vol.29, p.viii614-viii614

2018

Volltextzugriff (PDF)

Actionable mutations and overall survival in 3,211 patients with cancer: The Hellenic cooperative oncology group precision medicine initiative

Annals of oncology, 2018-10, Vol.29, p.viii664-viii664

2018

Volltextzugriff (PDF)

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study

British journal of cancer, 2008-12, Vol.99 (11), p.1775-1785

2008

Volltextzugriff (PDF)

Differential expression of γKlotho in triple negative and Her2-overexpressing breast cancer

Breast (Edinburgh), 2017-03, Vol.32, p.S93-S94

2017

Volltextzugriff (PDF)

A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: A Hellenic Cooperative Oncology Group study

Breast cancer research and treatment, 2009-05, Vol.115 (1), p.87-99

2009

Volltextzugriff (PDF)

1976 Significance of PIK3CA mutations in patients with early breast cancer treated with adjuvant chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) study

European journal of cancer (1990), 2015-09, Vol.51, p.S325-S326

2015

Volltextzugriff (PDF)

randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer

Breast cancer research and treatment, 2009-05, Vol.115 (1), p.87-99

2009

Volltextzugriff (PDF)

Stage I testicular seminoma: Management and controversies

Critical reviews in oncology/hematology, 2009-07, Vol.71 (1), p.22-28

2009

Volltextzugriff (PDF)

Association of CD133 polymorphisms and response to bevacizumab in patients with metastatic colorectal cancer

Cancer biomarkers : section A of Disease markers, 2015-11, Vol.15 (6), p.843-850

2015

Volltextzugriff (PDF)

Adult Granulosa Cell Tumors of the Ovary: A Clinicopathological Study of 34 Patients by the Hellenic Cooperative Oncology Group (HeCOG)

Anticancer research, 2008-03, Vol.28 (2B), p.1421-1427

2008

Volltextzugriff (PDF)

Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study

Annals of oncology, 2004-03, Vol.15 (3), p.493-497

2004

Volltextzugriff (PDF)

1 – 25 von 309

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(297)
Mit Volltextzugriff
(271)

Publikationsform

Artikel
(308)
Buchkapitel
(1)

Sprache

Englisch
(305)
Deutsch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(159)
Life Sciences & Biomedicine
(149)
Humans
(146)
Female
(123)
Adult
(111)
Biological And Medical Sciences
(108)
Medical Sciences
(104)
Middle Aged
(103)
Oncology
(100)
Aged
(99)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(68)
Male
(60)
Chemotherapy
(51)
Pharmacology. Drug Treatments
(51)
Tumors
(47)
Treatment Outcome
(46)
Antineoplastic Agents
(43)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(39)
Gynecology. Andrology. Obstetrics
(38)
Obstetrics & Gynecology
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(59)
Journal Of Clinical Oncology
(31)
European Journal Of Cancer
(17)
Anticancer Research
(15)
Oncology
(11)
International Journal Of Gynecology And Obstetrics
(8)
Value In Health
(8)
Gynecologic Oncology
(7)
Journal Of Hypertension
(7)
Urology
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer

The pharmacological treatment of aggressive fibromatosis: a systematic review

Cutaneous toxicities of antineoplastic agents: data from a large cohort of Greek patients

Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)

A multicenter phase III trial comparing irinotecan-gemcitabine (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer

Association between genetic polymorphisms in long non-coding RNAs and pancreatic cancer risk

Recurrence rate in colorectal adenocarcinoma patients receiving adjuvant capecitabine monotherapy: do the number of chemotherapy cycles and relative dose intensity of the drug play a role?

ABREAST: a prospective, real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and quality of life of patients with metastatic breast cancer

Afatinib in combination with cisplatin and 5-fluorouracil (5-FU) as first line treatment in inoperable gastric and gastro-esophageal junction (GEJ) cancer: A phase II study by the Hellenic Cooperative Oncology Group

Primary fallopian tube carcinoma: Results of a retrospective analysis of 64 patients

Cyclin D1 differential activation and its prognostic impact among advanced breast cancer patients treated with trastuzumab

Docetaxel and Cisplatin With Granulocyte Colony-Stimulating Factor (G-CSF) Versus MVAC With G-CSF in Advanced Urothelial Carcinoma: A Multicenter, Randomized, Phase III Study From the Hellenic Cooperative Oncology Group

Prevention and prophylaxis of thrombosis in cancer patients

Actionable mutations and overall survival in 3,211 patients with cancer: The Hellenic cooperative oncology group precision medicine initiative

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study

Differential expression of γKlotho in triple negative and Her2-overexpressing breast cancer

A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: A Hellenic Cooperative Oncology Group study

1976 Significance of PIK3CA mutations in patients with early breast cancer treated with adjuvant chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) study

randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer

Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group

Stage I testicular seminoma: Management and controversies

Association of CD133 polymorphisms and response to bevacizumab in patients with metastatic colorectal cancer

Adult Granulosa Cell Tumors of the Ovary: A Clinicopathological Study of 34 Patients by the Hellenic Cooperative Oncology Group (HeCOG)

Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study

Suchergebnisse filtern